Endovia Health Sciences (EDVA) Other Non-Current Assets (2018 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | 416,011.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 416,011.00 |
| Mar 31, 2026 | 17,594.00 |
| Dec 31, 2025 | 22,734.00 |
| Sep 30, 2025 | 48,922.00 |
| Jun 30, 2025 | 48,922.00 |
| Mar 31, 2025 | 118,922.00 |
| Dec 31, 2024 | 872,674.00 |
| Sep 30, 2024 | 49,849.00 |
| Jun 30, 2024 | 49,351.00 |
| Mar 31, 2024 | 49,462.00 |
| Dec 31, 2023 | 49,446.00 |
| Sep 30, 2023 | 49,398.00 |
| Jun 30, 2023 | 49,431.00 |
| Mar 31, 2023 | 49,368.00 |
| Dec 31, 2022 | 49,290.00 |
| Sep 30, 2022 | 49,251.00 |
| Jun 30, 2022 | 94,674.00 |
| Mar 31, 2022 | 252,297.00 |
| Dec 31, 2021 | 473,461.00 |
| Sep 30, 2021 | 410,279.00 |